Buy or sell Kallyope stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Kallyope Stock

Kallyope is a healthcare company focusing on biotechnology business.

Founded

2015

Notable Investors

Illumina

Headquarters

New York NY, US

Total Funding

$110M

About Kallyope Stock

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the gut informs our brains about our well-being, metabolism, and nutritional state. The gut-brain axis—the communication highway between our gut and our brain—offers an unprecedented opportunity to access and influence brain centers involved in fundamental human processes. An understanding of the biology mediated by the gut and gut-brain circuits will change the way we think about food, nutrition, and human physiology

Investors

Funding History

December 2015$44.0M
February 2018$66.0M

Management

CEO

Nancy Thornberry

Founder

Tom Maniatis

Founder

Charles Zuker

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Kallyope or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo